Arli Aditya Parikesit

Author

Also Known As

A A Parikesit, A. A. Parikesit, A.A. Parikesit, AA Parikesit, ADITYA PARIKESIT ARLI, ARLI ADITYA PARIKESIT, Aditya Arli, Aditya Parikesit Arli, Arli A Parikesit, Arli A. PARIKESIT

234

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

University of Indonesia Indonesia International Institute for Life Sciences Airlangga University Leipzig University Ministry of Agriculture

About

Arli Aditya Parikesit is an author at University of Indonesia specializing in medicine, virology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	17	322
2	Natural Sciences	6	6	90
3	Engineering	5	5	81
4	Biochemistry	5	5	79
5	Public Health	1	1	56

Arli Aditya Parikesit

Publications

704

Citations

H-Index

Page 1

	Year	Citations
COVID-19 In Silico Drug with Zingiber officinale Natural Product Compound Library Targeting the Mpro Protein Renadya Maulani Wijaya, Muhammad Aldino Hafidzhah, Viol Dhea Kharisma, Makara Journal of Science	2021	80
Effect of Biosynthesized Silver Nanoparticles on Bacterial Biofilm Changes in S. aureus and E. coli Božena Hosnedlová, Daniil Kabanov, Marta Kepinská, Nanomaterials	2022	74
Genetic Variant of SARS-CoV-2 Isolates in Indonesia: Spike Glycoprotein Gene Arif Nur Muhammad Ansori, Viol Dhea Kharisma, Sahal Sabilil Muttaqin, Journal of Pure and Applied Microbiology Viral DiagnosticsViral PathogenesisImmunologyPathologyCovid-19 Epidemiology	2020	56
In silico modification of suberoylanilide hydroxamic acid (SAHA) as potential inhibitor for class II histone deacetylase (HDAC) Usman Sumo Friend Tambunan, N Bramantya, Arli Aditya Parikesit BMC Bioinformatics	2011	34
The whole-genome sequencing in predicting Mycobacterium tuberculosis drug susceptibility and resistance in Papua, Indonesia Yustinus Maladan, Hana Krismawati, Tri Wahyuni, BMC Genomics	2021	29
Screening of commercial cyclic peptide as inhibitor NS5 methyltransferase of Dengue virus through Molecular Docking and Molecular Dynamics Simulation Usman Sumo Friend Tambunan, Hilyatuz Zahroh, Bimo Budi Utomo, Bioinformation	2014	28
Screening of Commercial Cyclic Peptides as Inhibitor Envelope Protein Dengue Virus (DENV) Through Molecular Docking and Molecular Dynamics Arli Aditya Parikesit, Kinanty, Usman Sumo Friend Tambunan Pakistan Journal of Biological Sciences Virus StructureBiochemistryEnvelope ProteinProtein FoldingCommercial Cyclic Peptides	2013	27
Molecular simulation of compounds from n-hexane fraction of Sonchus arvensis L. leaves as SARS-CoV-2 antiviral through inhibitor activity targeting strategic viral protein Dwi Kusuma Wahyuni, Sumrit Wacharasindhu, Wichanee Bankeeree, Journal of Pharmacy & Pharmacognosy Research Molecular PharmacologyMolinspiration ServerLipinski RuleMedicineAntiviral Drug Development	2022	27
Screening of commercial cyclic peptide conjugated to HIV-1 Tat peptide as inhibitor of N-terminal heptad repeat glycoprotein-2 ectodomain Ebola virus through in silico analysis Usman Sumo Friend Tambunan, Ahmad Husein Alkaff, Mochammad Arfin Fardiansyah Nasution, Journal of Molecular Graphics and Modelling Silico AnalysisHuman RetrovirusImmunologyAntiviral ResponseAntiviral Drug Development	2017	24
Modification of<i>S</i>-Adenosyl-<scp>l</scp>-Homocysteine as Inhibitor of Nonstructural Protein 5 Methyltransferase Dengue Virus Through Molecular Docking and Molecular Dynamics Simulation Usman Sumo Friend Tambunan, Mochammad Arfin Fardiansyah Nasution, Fauziah Azhima, Drug Target Insights	2017	24

Page 1